全文获取类型
收费全文 | 748篇 |
免费 | 40篇 |
国内免费 | 15篇 |
专业分类
儿科学 | 13篇 |
妇产科学 | 12篇 |
基础医学 | 21篇 |
临床医学 | 66篇 |
内科学 | 34篇 |
皮肤病学 | 9篇 |
神经病学 | 6篇 |
特种医学 | 17篇 |
外科学 | 225篇 |
综合类 | 124篇 |
预防医学 | 34篇 |
眼科学 | 5篇 |
药学 | 130篇 |
中国医学 | 12篇 |
肿瘤学 | 95篇 |
出版年
2023年 | 12篇 |
2022年 | 20篇 |
2021年 | 18篇 |
2020年 | 22篇 |
2019年 | 16篇 |
2018年 | 25篇 |
2017年 | 27篇 |
2016年 | 30篇 |
2015年 | 27篇 |
2014年 | 39篇 |
2013年 | 59篇 |
2012年 | 56篇 |
2011年 | 47篇 |
2010年 | 37篇 |
2009年 | 40篇 |
2008年 | 44篇 |
2007年 | 38篇 |
2006年 | 30篇 |
2005年 | 27篇 |
2004年 | 27篇 |
2003年 | 23篇 |
2002年 | 20篇 |
2001年 | 14篇 |
2000年 | 15篇 |
1999年 | 12篇 |
1998年 | 7篇 |
1997年 | 7篇 |
1996年 | 4篇 |
1995年 | 4篇 |
1994年 | 14篇 |
1993年 | 4篇 |
1992年 | 2篇 |
1991年 | 4篇 |
1990年 | 3篇 |
1989年 | 2篇 |
1988年 | 8篇 |
1987年 | 5篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1976年 | 1篇 |
排序方式: 共有803条查询结果,搜索用时 15 毫秒
21.
22.
Non‐muscle invasive bladder cancer and bacillus Calmette‐Guerin treatment: a review of the literature
下载免费PDF全文
![点击此处可从《International Journal of Urological Nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Jason Alcorn BSc MSc Rob L Burton RNLD BSc Cert.Ed M.Ed Ed.D Annie Topping RN PhD PGCE BSc 《International Journal of Urological Nursing》2015,9(2):57-68
Bladder cancer is the second most common urological cancer in the UK, with over 10 000 cases diagnosed annually. With 80% of urothelial bladder cancers being non‐muscle invasive, it is important to understand the treatments available. This review aims to identify and review the literature regarding bacillus Calmette‐Guerin (BCG) treatment. An integrative‐based review was conducted to generate a broad overview of the existing knowledge for BCG treatment. An open search of online databases was conducted to identify articles published in English from the earliest date available to September 2013, using key terms related to BCG. A significant number of articles were identified. To narrow the results and identify the most relevant articles, the search terms were cross‐referenced. The resulting articles were then reviewed using the critical appraisal skills programme framework. The tools provided by CASP give a systematic, transparent and rigorous approach to the quality assessment of research studies. The research articles were then categorized under the following headings: side effects, including local, systemic and age; quality of life; and attrition. The major conclusion from this literature review is that BCG treatment, when given through an induction and maintenance regime, significantly reduces the risk of progression and recurrence. However, there are potential side effects which the patient and the nurse need to be aware. This review also highlighted that there is a lack of research from the UK and that there is a paucity of research showing why patients withdraw from BCG treatment 相似文献
23.
24.
Luigi Bernini Carlo Umberto Manzini Dilia Giuggioli Marco Sebastiani Clodoveo Ferri 《Autoimmunity reviews》2013,12(12):1150-1159
Objective
Intravesical instillation of BCG (ivBCG) is an effective and safe immunotherapy of bladder carcinoma but it may have, as side effect, a reactive arthritis (ReA). The authors describe 5 cases observed during their own clinical experience along with the updated review of the literature on this topic.Methods
Seventy-three papers were present in the world literature, each reporting almost 1 case for a total of 112 patients. However, the review focused on 61 papers, selected on the basis of reporting suitable for a correct clinical evaluation; thus, a total of 89 patients, including the cases observed in our clinic, were carefully analyzed.Results
Among the 89 patients identified 73 were males and 16 females. Europe is the geographical area with the higher number of reports, namely 80.6% of the papers including 74.2% of the patients. The Mediterranean area accounts for 62.9% of the papers and 59.6% of the cases. The symptoms of ReA appeared after a mean number of instillations of 5.8. Polyarthritis was present in 55.1%, oligoarthritis in 37.0% and monoarthritis in 7.9%. Polyarthritis was symmetric in 51.0% and asymmetric in 49.0% of the cases; oligoarthritis was symmetric in 33.3% and asymmetric in 66.7% of the cases. Overall, an asymmetric distribution of arthritis was present in 59.6%. Knee and ankle were the joints most frequently involved. The antigen HLA B27 was positive in 42.6%. The synovial fluid analysis was defined as flogistic–aseptic in 71.9% of the patients. Arthritis was recovered within 6 months in 93.2% of the cases and in 70.5% of the patients within the first two months. NSAIDs and corticosteroids, alone or in conjunction with other drugs, are used in 65.1% and in 40.4% of the cases, respectively. The clinical features of ivBCG ReA are compared with ReA from other triggering agents, from which it differs for some clinical aspects and overlaps for others.Conclusions
Compared with a previous report, this review allows to modify some figures of this topic as a reduced prevalence of polyarthritis (from 70% to 55.1%) and of spinal and sacroiliac involvement; polyarthritis remains the more frequent clinical pattern of ivBCG ReA that, however, is characterized by rather asymmetrical distribution and involvement of the large joints of lower limbs. A definite linkage to HLA B27 is present, although without prognostic value. Moreover, arthritis is aseptic, has a latency time from antigen exposure, and is associated with extra-articular features as commonly observed in ReA from other triggering agents. Arthritis is usually benign and rarely develops into a chronic form. NSAIDs and/or corticosteroids are largely effective. Noteworthy, the overall clinical picture of arthritis triggered by ivBCG emerging from this updated review is comparable to that of ReA from other bacterial agents. 相似文献25.
目的:总结吡柔比星(THP)膀胱灌注联合乌苯美司片预防浅表性膀胱癌术后复发的疗效及安全性。方法:2008年10月~20n年10月对103例浅表性膀胱尿路上皮癌患者行经尿道膀胱肿瘤切除(TURBT)术,术后分成两组,其中THP膀胱灌注联合鸟苯美司片组56例,单纯THP膀胱灌注组47例。THP灌注方法为30mg/次,每次膀胱内保留30min,每周1次共8次,然后每月1次共8次;乌苯美司片服法30mg/d,早晨顿服,连用10个月。定期行膀胱镜检查。结果:103例患者获得随访,平均随访(12.5±6.28)个月,THP联合乌苯美司组1年和2年复发率分别为8.9%和10.7%;单纯THP组1年和2年复发率分别为12.8%和19.1%,差异有统计学意义。THP联合乌苯美司组副作用主要为膀胱刺激征及轻微血尿,全身副作用少,症状轻,较单纯THP组无明显差异。结论:THP膀胱灌注联合乌苯美司片预防浅表性膀胱癌术后复发疗效满意,副作用以下尿路局部症状为主,安全性好。 相似文献
26.
Maximilian Burger Willem Oosterlinck Badrinath Konety Sam Chang Sigurdur Gudjonsson Raj Pruthi Mark Soloway Eduardo Solsona Paul Sved Marko Babjuk Maurizio A. Brausi Christopher Cheng Eva Comperat Colin Dinney Wolfgang Otto Jay Shah Joachim Thürof J. Alfred Witjes 《European urology》2013
Context
Our aim was to present a summary of the Second International Consultation on Bladder Cancer recommendations on the diagnosis and treatment options for non–muscle-invasive urothelial cancer of the bladder (NMIBC) using an evidence-based approach.Objective
To critically review the recent data on the management of NMIBC to arrive at a general consensus.Evidence acquisition
A detailed Medline analysis was performed for original articles addressing the treatment of NMIBC with regard to diagnosis, surgery, intravesical chemotherapy, and follow-up. Proceedings from the last 5 yr of major conferences were also searched.Evidence synthesis
The major findings are presented in an evidence-based fashion. We analyzed large retrospective and prospective studies.Conclusions
Urothelial cancer of the bladder staged Ta, T1, and carcinoma in situ (CIS), also indicated as NMIBC, poses greatly varying but uniformly demanding challenges to urologic care. On the one hand, the high recurrence rate and low progression rate with Ta low-grade demand risk-adapted treatment and surveillance to provide thorough care while minimizing treatment-related burden. On the other hand, the propensity of Ta high-grade, T1, and CIS to progress demands intense care and timely consideration of radical cystectomy. 相似文献27.
Wolfgang G. Kreyling Uwe Holzwarth Nadine Haberl Ján Kozempel Alexander Wenk Stephanie Hirn 《Nanotoxicology》2017,11(4):454-464
The biokinetics of a size-selected fraction (70?nm median size) of commercially available and 48V-radiolabeled [48V]TiO2 nanoparticles has been investigated in healthy adult female Wistar-Kyoto rats at retention time-points of 1?h, 4?h, 24?h, 7?d and 28?d after intratracheal instillation of a single dose of an aqueous [48V]TiO2-nanoparticle suspension. A completely balanced quantitative biodistribution in all organs and tissues was obtained by applying typical [48V]TiO2-nanoparticle doses in the range of 40–240?μg·kg?1 bodyweight and making use of the high sensitivity of the radiotracer technique. The [48V]TiO2-nanoparticle content was corrected for residual blood retained in organs and tissues after exsanguination and for 48V-ions not bound to TiO2-nanoparticles. About 4% of the initial peripheral lung dose passed through the air-blood-barrier after 1?h and were retained mainly in the carcass (4%); 0.3% after 28?d. Highest organ fractions of [48V]TiO2-nanoparticles present in liver and kidneys remained constant (0.03%). [48V]TiO2-nanoparticles which entered across the gut epithelium following fast and long-term clearance from the lungs via larynx increased from 5 to 20% of all translocated/absorbed [48V]TiO2-nanoparticles. This contribution may account for 1/5 of the nanoparticle retention in some organs. After normalizing the fractions of retained [48V]TiO2-nanoparticles to the fraction that reached systemic circulation, the biodistribution was compared with the biodistributions determined after IV-injection (Part 1) and gavage (GAV) (Part 2). The biokinetics patterns after IT-instillation and GAV were similar but both were distinctly different from the pattern after intravenous injection disproving the latter to be a suitable surrogate of the former applications. Considering that chronic occupational inhalation of relatively biopersistent TiO2-particles (including nanoparticles) and accumulation in secondary organs may pose long-term health risks, this issue should be scrutinized more comprehensively. 相似文献
28.
29.
Jason D. Hehr Trevor S. Hodson Julie M. West Steven A. Schulz Stephen J. Poteet Rajiv Y. Chandawarkar Ian L. Valerio 《International wound journal》2020,17(2):387-393
Wound infection involving hardware can be notoriously difficult to treat, often requiring the removal of the infected implant. The goal of this study was to determine the utility of instillation negative pressure wound therapy to help eradicate infection and allow for definitive wound closure in patients without removing the infected hardware. A retrospective review was performed on the outcomes of 28 patients who presented with open wounds with exposed or infected hardware and who were treated with a combination of surgical debridement and negative pressure wound therapy with instillation (NPWTi). Eleven patients were treated for infected spinal hardware, 12 for extremity, and 5 for sternal hardware. Twenty‐five of 28 (89%) patients had successful retention or replacement of hardware, with clearance of infection and healed wounds. Original hardware was maintained in 17 of 28 (61%) patients. In 11 patients, original hardware was removed, with subsequent replacement in eight of those patients after a clean wound was achieved. Average time to definitive closure was 12.6 days. Average follow‐up was 135 days. This series supports NPWTi as an effective adjunct therapy to help expeditiously eradicate hardware infection, allowing for hardware retention. 相似文献
30.